scleroderma

Correspondence on ‘Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial’
Markus Bredemeier

Annals of the Rheumatic Diseases Dec 2022, 81 (12) e250; DOI: 10.1136/annrheumdis-2020-218911
Response to: ‘Correspondence on ‘Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial’’ by Bredemeier
James R Seibold, Veronika Kohlbrenner, Margarida Alves, Oliver Distler

Annals of the Rheumatic Diseases Dec 2022, 81 (12) e251; DOI: 10.1136/annrheumdis-2020-218960
Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over time
Brian Skaug, Marka A Lyons, William R Swindell, Gloria A Salazar, Minghua Wu, Tuan M Tran, Julio Charles, Connor P Vershel, Maureen D Mayes, Shervin Assassi

Annals of the Rheumatic Diseases Apr 2022, 81 (4) 516-523; DOI: 10.1136/annrheumdis-2021-221352
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
Mike O Becker, Rucsandra Dobrota, Alexandru Garaiman, Rudolf Debelak, Kim Fligelstone, Ann Tyrrell Kennedy, Annelise Roennow, Yannick Allanore, Patricia E Carreira, László Czirják, Christopher P Denton, Roger Hesselstrand, Gunnel Sandqvist, Otylia Kowal-Bielecka, Cosimo Bruni, Marco Matucci-Cerinic, Carina Mihai, Ana Maria Gheorghiu, Ulf Mueller-Ladner, Joseph Sexton, Tore K Kvien, Turid Heiberg, Oliver Distler

Annals of the Rheumatic Diseases Apr 2022, 81 (4) 507-515; DOI: 10.1136/annrheumdis-2021-220702
Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung disease
Shervin Assassi, Elizabeth R Volkmann, W Jim Zheng, Xuan Wang, Holly Wilhalme, Marka A Lyons, Michael D Roth, Donald P Tashkin

Annals of the Rheumatic Diseases Jun 2022, 81 (6) 854-860; DOI: 10.1136/annrheumdis-2021-221313
Correspondence on ‘Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension’
Michele Iudici, Danièle Allali, Raphaël Porcher

Annals of the Rheumatic Diseases Mar 2023, 82 (3) e65; DOI: 10.1136/annrheumdis-2020-219568
Response to: ‘ Correspondence on ‘Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension’’ by Iudici et al
Ekkehard Grünig, Nicola Benjamin, Panagiota Xanthouli, Suzana Jordan, Nicklas Milde, Alberto Marra, Norbert Blank, Benjamin Egenlauf, Matthias Gorenflo, Satenik Harutyunova, Hanns-Martin Lorenz, Christian Nagel, Vivienne Theobald, Mona Lichtblau, Charlotte Berlier, Silvia Ulrich, Oliver Distler

Annals of the Rheumatic Diseases Mar 2023, 82 (3) e66; DOI: 10.1136/annrheumdis-2020-219597
Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern
Jean-Baptiste Vulsteke, Yves Piette, Carolien Bonroy, Patrick Verschueren, Daniel Blockmans, Steven Vanderschueren, Kristl G Claeys, Petra De Haes, Jan Leo Lenaerts, Wim A Wuyts, Takashi Matsushita, Vanessa Smith, Ellen De Langhe, Xavier Bossuyt

Annals of the Rheumatic Diseases May 2022, 81 (5) 742-744; DOI: 10.1136/annrheumdis-2021-220004
COVID-19 in Italian patients with rheumatic autoimmune systemic diseases
Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Poupak Fallahi, Alessandro Antonelli

Annals of the Rheumatic Diseases Sep 2023, 82 (9) e211; DOI: 10.1136/annrheumdis-2020-219113
Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic—World Scleroderma Foundation preliminary advice for patient management’
Elena Snarskaya, Kseniia Vasileva

Annals of the Rheumatic Diseases Feb 2023, 82 (2) e36; DOI: 10.1136/annrheumdis-2020-219489

Main menu

scleroderma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

scleroderma

Pages